Skip to main content

Advertisement

SpringerLink
Log in

C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Dysregulation of the immune system may play important roles in the development of colorectal cancer (CRC). The C-X-C chemokine receptor type 5 (CXCR5) is one of the principal regulators for targeting T cells, B cells, and dendritic cells into secondary lymphoid organs. The current study investigated the association between CXCR5 gene polymorphisms and the risk of CRC, and the potential effect of these polymorphisms on different immune cells. Two polymorphisms in CXCR5 gene, rs6421571C/T and rs80202369G/A, were examined by polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) in 302 cases and 316 controls. Results showed that individuals with the rs6421571CT and TT genotypes had a strong correlation with the incidence of CRC (odds ratio (OR) = 1.46; 95 % confidence interval (CI), 1.02–2.09; p = 0.041 and OR = 2.62; 95 % CI, 1.50–4.95; p < 0.001, respectively). Also, rs80202369AA genotype revealed significantly higher distribution in CRC patients than in controls (p = 0.002). We further investigated the possible effects of the polymorphisms by assessing messenger RNA (mRNA) and protein levels of CXCR5 in peripheral blood mononuclear cells (PBMCs), CD4+ T cells, CD8+ T cells, and B cells. Data presented that healthy controls with rs6421571CT and TT genotypes had higher mRNA and protein levels of CXCR5 than those with wild-type CC genotype specifically in CD4+ T cells. These findings suggest novel risk factors of CRC and indicate a potential mechanism of CXCR5 gene polymorphism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Karantanos T, Theodoropoulos G, Pektasides D, Gazouli M. Clock genes: their role in colorectal cancer. World J Gastroenterol. 2014;20:1986–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim Biophys Acta. 2014.

  3. Biswas S, Sengupta S, Roy Chowdhury S, Jana S, Mandal G, et al. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Breast Cancer Res Treat. 2014;143:265–76.

    Article  CAS  PubMed  Google Scholar 

  4. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 2014;10:e1003853.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Charbonneau B, Wang AH, Maurer MJ, Asmann YW, Zent CS, et al. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis. Cancer Immunol Immunother. 2013;62:1475–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Humpert ML, Pinto D, Jarrossay D, Thelen M. CXCR7 influences the migration of B cells during maturation. Eur J Immunol. 2014;44:694–705.

    Article  CAS  PubMed  Google Scholar 

  7. Kobayashi S, Murata K, Shibuya H, Morita M, Ishikawa M, et al. A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. Arthritis Rheum. 2013;65:3063–72.

    Article  CAS  PubMed  Google Scholar 

  8. Li Y, Ma S, Tang L, Li Y, Wang W, et al. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology. 2013;58:1277–86.

    Article  PubMed  Google Scholar 

  9. Park HJ, Kim DH, Lim SH, Kim WJ, Youn J, et al. Insights into the role of follicular helper T cells in autoimmunity. Immune Netw. 2014;14:21–9.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Shi W, Li X, Cha Z, Sun S, Wang L, et al. Dysregulation of circulating follicular helper T cells in nonsmall cell lung cancer. DNA Cell Biol. 2014.

  11. Stuart MJ, Corrigan F, Baune BT. Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus. J Neuroinflammation. 2014;11:31.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Xiao H, Luo G, Son H, Zhou Y, Zheng W. Upregulation of peripheral CD4+CXCR5+ T cells in osteosarcoma. Tumour Biol. 2014.

  13. Barroso R, Martinez Munoz L, Barrondo S, Vega B, Holgado BL, et al. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J. 2012;26:4841–54.

    Article  CAS  PubMed  Google Scholar 

  14. Jiang J, Karimi O, Ouburg S, Champion CI, Khurana A, et al. Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection. PLoS One. 2012;7:e47487.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Leon B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, et al. Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat Immunol. 2012;13:681–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Pallikkuth S, Parmigiani A, Silva SY, George VK, Fischl M, et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood. 2012;120:985–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Ransohoff RM, et al. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS. J Neuroimmunol. 2012;243:81–8.

    Article  CAS  PubMed  Google Scholar 

  18. Quan C, Yu H, Qiao J, Xiao B, Zhao G, et al. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Mult Scler. 2013;19:289–98.

    Article  PubMed  Google Scholar 

  19. Razis E, Kalogeras KT, Kotoula V, Eleftheraki AG, Nikitas N, et al. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression. Clin Breast Cancer. 2012;12:183–93.

    Article  CAS  PubMed  Google Scholar 

  20. Sambandam Y, Sundaram K, Liu A, Kirkwood KL, Ries WL, et al. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment. Oncogene. 2013;32:97–105.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Smedbakken LM, Halvorsen B, Daissormont I, Ranheim T, Michelsen AE, et al. Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis—potential role in plaque stabilization. Atherosclerosis. 2012;224:266–73.

    Article  CAS  PubMed  Google Scholar 

  22. Song H, Tong D, Cha Z, Bai J. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma. Mol Biol Rep. 2012;39:8629–35.

    Article  CAS  PubMed  Google Scholar 

  23. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621–63.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China

    Junjie Xing, Xu Li, Jinke Sui & Chuangang Fu

  2. Department of Epidemiology, Second Military Medical University, 800 Xiangyin Rd., Shanghai, 200433, China

    Guangwen Cao

Authors
  1. Junjie Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinke Sui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guangwen Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chuangang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Junjie Xing, Guangwen Cao or Chuangang Fu.

Additional information

Junjie Xing, Xu Li, and Jinke Sui contributed equally to the work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xing, J., Li, X., Sui, J. et al. C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer. Tumor Biol. 35, 7929–7934 (2014). https://doi.org/10.1007/s13277-014-2069-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2069-8

Keywords

Search

Navigation